Pharma Marketing and GlaxoSmithKline

Selected news for the healthcare topic - Pharma Marketing, and the company - GlaxoSmithKline We have 6 shared news items for this connection to-date.

Please provide a valid email address.
Pharma Marketing Shares Healthcare News With (link):
Healthcare Topics
Companies
Health Systems

Selected Headlines

Date Headline (link) Source Relevant Snippet
11/2/2020 Bayer, ViiV and RB challenge limits of pharma marketing creativity with innovative thinking, executions and media FiercePharma With Alka Seltzer rockets, off-Broadway shows and cold-and-flu brand loungewear, who says pharma marketing can’t be creative? Not Bayer, RB and GlaxoSmithKline’s ViiV Healthcare. The companies' modern marketing methods are upending traditional—and often formulaic—industry advertising efforts.Executives from the three companies recently discussed pharma's creativity in general, along with specific efforts that included the Alka Seltzer rocket competitions (Bayer), off-Broadway shows (ViiV ...
7/12/2019 Indivior's former parent ponies up a whopping $1.4B to settle Suboxone marketing probe | FiercePharma FiercePharma ... pharma marketing, with only a handful of drugmakers ever having paid billion-dollar settlements. The single largest settlement on record was GlaxoSmithKline's criminal and civil payout of $3 billion in 2012, with the most recent seven-figure check signed by Teva in 2015 for $1.2 billion Reckitt's settlement only covers allegations dating to the period before Indivior's 2014 spinoff, Indivior said in a statement. Reckitt was not directly named in ...
7/11/2019 Indivior's former parent ponies up a whopping $1.4B to settle Suboxone marketing probe FiercePharma ... pharma marketing, with only a handful of drugmakers ever having paid billion-dollar settlements. The single largest settlement on record was GlaxoSmithKline's criminal and civil payout of $3 billion in 2012, with the most recent seven-figure check signed by Teva in 2015 for $1.2 billion Register Today Reckitt's settlement only covers allegations dating to the period before Indivior's 2014 spinoff, Indivior said in a statement. Reckitt was not directly ...
7/9/2019 Global Digital Pharma Marketing Trends 2019 - Featuring Bayer HealthCare, GlaxoSmithKline, Johnson & Johnson, Novartis, Novo Nordisk, and Roche | Benzinga Trends in Digital Pharma Marketing" What are the trends and developments that will drive pharma's digital marketing initiatives? What are the trends that are shaping digital pharma marketing? How will the increased investment be used ... become over the next 5 years? Companies Mentioned Bayer HealthCare GlaxoSmithKline Johnson & Johnson Novartis Novo Nordisk Roche //www.researchandmarkets.com/r/mkkch7 Pharmaceuticals, Online Advertising ...
7/9/2019 Global Digital Pharma Marketing Trends 2019 - Featuring Bayer HealthCare, GlaxoSmithKline, Johnson & Johnson, Novartis, Novo Nordisk, and Roche Globe Newswire July 09, 2019 04:35 ET Source: Research and Markets Dublin, July 09, 2019 (GLOBE NEWSWIRE) -- The "Trends in Digital Pharma Marketing" report has been added to ResearchAndMarkets.com's offering. What are the trends and developments that will drive pharma's digital marketing initiatives? What are the trends that are shaping digital pharma marketing? How will the increased investment be used to drive the digital marketing agenda How are digital marketing channels being ...
7/9/2019 Global Digital Pharma Marketing Trends 2019 – Featuring Bayer HealthCare, GlaxoSmithKline, Johnson & Johnson, Novartis, Novo Nordisk, and Roche | Financial Buzz Dublin, The “Trends in Digital Pharma Marketing” report has been added to ResearchAndMarkets.com’s offering. What are the trends and developments that will drive pharma’s digital marketing initiatives? What are the trends that are shaping digital ... become over the next 5 years? Companies Mentioned Bayer HealthCare GlaxoSmithKline Johnson & Johnson Novartis Novo Nordisk Roche For more information about this report visit https://www.researchandmarkets.com/r/mkkch7 Research and Markets also offers Custom Research ...